Slate Run Pharmaceuticals FDA Record
- Latest inspection NAI · Dec 5, 2024
- No warning letters matched by name
Slate Run Pharmaceuticals has 3 FDA recalls, 1 inspection, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "Slate Run Pharmaceuticals" is on file.
- Latest recall
- D-0343-2026 · Class III · Feb 12, 2026
- Latest inspection
- Dec 5, 2024 · NAI
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 3 | Nov 11, 2026 (checked Nov 15, 2026, unchanged) | File dated Nov 10, 2026 | Current |
| 510(k) clearances | 0 | Nov 15, 2026 | File dated Nov 9, 2026 | Current |
| Inspections | 1 | Nov 16, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions | 0 | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
FDA record by year
Slate Run Pharmaceuticals: FDA inspections per year
| Year | Inspections | OAI | Warning letters | Recall records | Class I |
|---|---|---|---|---|---|
| 2026 | 0 | 0 | 0 | 1 | 0 |
| 2025 | 0 | 0 | 0 | 2 | 0 |
| 2024 | 1 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 |
| 2022 | 0 | 0 | 0 | 0 | 0 |
| 2021 | 0 | 0 | 0 | 0 | 0 |
| 2020 | 0 | 0 | 0 | 0 | 0 |
| 2019 | 0 | 0 | 0 | 0 | 0 |
| 2018 | 0 | 0 | 0 | 0 | 0 |
| 2017 | 0 | 0 | 0 | 0 | 0 |
Reviewing Slate Run Pharmaceuticals as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Slate Run Pharmaceuticals yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Recent recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0343-2026 | Class III | Eptifibatide Injection, 75 mg/100 mL vial for weight-adjusted bolus dosing, 1x100 mL Single-dose… | Feb 12, 2026 |
| D-0279-2025 | Class II | Cinacalcet Hydrochloride Tablets 60 mg, 30-count bottle, Rx only, Distr. by: Slate Run Pharma., LLC… | Mar 7, 2025 |
| D-0278-2025 | Class II | Cinacalcet Hydrochloride Tablets 30 mg, 30-count bottle, Rx only, Distr. by: Slate Run Pharma., LLC… | Mar 7, 2025 |
Recent FDA inspections
| Date | Site | Product | Classification | FEI |
|---|---|---|---|---|
| Dec 5, 2024 | Columbus, OH | Drugs | No Action Indicated (NAI) | 3012729077 |
- NAI
- No objectionable conditions or practices were found during the inspection.
- VAI
- Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
- OAI
- Regulatory and/or administrative actions are recommended.
FDA-inspected facilities
| Facility | Location | Inspections | Latest |
|---|---|---|---|
| FEI 3012729077 | Columbus, OH | 1 | Dec 5, 2024 |
Slate Run Pharmaceuticals and the FDA: common questions
Has Slate Run Pharmaceuticals received an FDA warning letter?
No FDA warning letter addressed to the name "Slate Run Pharmaceuticals" is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.
Has Slate Run Pharmaceuticals received an FDA Form 483?
FDA has not published a Form 483 for "Slate Run Pharmaceuticals" in its reading room. FDA publishes some Form 483s, not all of them.
When did the FDA last inspect Slate Run Pharmaceuticals?
The most recent FDA inspection on file ended Dec 5, 2024 at Columbus, OH and was classified NAI. FDA has 1 inspection of Slate Run Pharmaceuticals on file.
Has Slate Run Pharmaceuticals had an FDA recall?
Yes. Slate Run Pharmaceuticals has 3 FDA recalls on record. The most recent started Feb 12, 2026.
Need more than this page shows? Ask about Slate Run Pharmaceuticals in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.